MS News Today Moderator

Has anyone ever told you to be thankful that things aren’t worse after getting upsetting news? Have you ever felt pressured to be grateful, even during the toughest moments? These are examples of #toxicpositivity. Toxic positivity is a distorted belief that pervasive happiness is the key to wellness, and positivity the only acceptable e…[Read more]

Relapsing MS patients have lower relapse risk, less disability progression, and fewer side effects with Zeposia than Aubagio, an indirect comparison study says. Click here to learn more.

Do these findings surprise you? Why or why not?

Global trials in relapsing and primary progressive MS are underway comparing oral fenebrutinib to Aubagio (relapsing MS) or Ocrevus (PPMS). Click here to find out more.

Will you be following these trials closely?

According to some US data, RRMS patients using oral DMTS generally tolerate them well, with side effects similar to trials and high adherence. Read more here.

Does this reflect your experience?

COVID-19 was two times more likely to be severe in MS patients on anti-CD20 therapies than untreated patients, data analyses in Italy report. Click here to read the full story.

Does this news surprise you?

Ocrevus started early in MS patients can substantially lower disease activity and lessen damage to the nervous system, researchers report. Read more here.

Have you tried Ocrevus? What was your experience with it?

The FDA has rejected Tysabri for MS. Click here to find out why.

How do you feel about this decision?

Phase 3 trial data show CIS patients on Mavenclad within 13 weeks had a lower lesion number and volume, and a lesser risk of MS onset. Click here to read more.

Do these findings surprise you? Why or why not?

Click here to read Ed Tobias’ round-up of the week’s top MS news stories, including an update about the FDA’s approval of the oral treatment Ponvory (ponesimod).

Which of these stories is most interesting to you?

The U.S. Food and Drug Administration (FDA) has approved Ponvory (ponesimod) as an oral treatment for adults with relapsing forms of multiple sclerosis. Click here to read the full story.

Does this news impact you or someone you know? How do you feel about it?

An MS diagnosis is life-changing for patients as well as for their family members and caregivers. A sea of medical documents, endless lifestyle changes and, perhaps most difficult, coping with new physical limitations, can change your very sense of self.

Click here to find out how you can regain control of your life amidst all this change.…[Read more]

The National Multiple Sclerosis Society issued dosing recommendations for MS disease-modifying therapies (DMTs) for COVID-19 vaccinations. Click here to find out what they are.

What do you think of these recommendations?

An early study based on medical claims filed by MS patients in US during unusually warm months estimate a ‘meaningful’ rise in healthcare use. Read the full story here.

What are your thoughts on this news?

Love isn’t all sunshine and flowers — it can take many forms, and often involves service and sacrifice. Click here to read a column about what love really looks like by Jamie Hughes.

What did you think of this column? How does your partner make you feel loved, and vice versa?

A safety board had recommended that a Phase 2a trial evaluating temelimab for relapsing MS should continue as planned, without modifications. Click here to read the full story.

Did you enjoy this article?

Many women have questions about getting pregnant and the impact of raising children on their own health when they live with a chronic illness like MS. Visit our forums to read about four things to consider if you’re planning to start a family soon.

Did you find this article helpful? What other concerns do you have about pregnancy, motherhood, etc?

When a new symptom develops, columnist Jessie Ace often hesitates to call her MS nurse. Click here to find out what happens when she does.

Can you relate to Jessie? What do you think stops you from reaching out for help when you need it?

The study of temelimab has enrolled 42 people with relapsing MS whose disability progressed in the absence of relapses after treatment with rituximab. Click here to learn more.

Are you following this study? What do you think of the findings so far?

People with multiple sclerosis who smoke tobacco or are not physically active are more likely to experience fatigue, a new study suggests. Click here to learn more.

Do these findings surprise you? Why or why not?

Bristol Myers Squibb and the American Music Therapy Association have partnered with Ben Platt and Courtney Platt to launch MS in Harmony. Read more about this new initiative here.

Have you tried or are you interested in trying music therapy?